Bone damage related to increased bone resorption is a feature of many cancers. Bisphosphonates are drugs that inhibit this process by reducing the number and activity of osteoclasts. They are often used in the treatment of patients with cancer to relieve bone pain, reduce the risk of fractures, and manage hypercalcemia.